A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults.
Issaka Sagara, Ruth D Ellis, Alassane Dicko, Mohamed B Niambele, Beh Kamate, Ousmane Guindo, Mahamadou S Sissoko, Michael P Fay, Merepen A Guindo, Ousmane Kante, Renion Saye, Kazutoyo Miura, Carole Long, Gregory E D Mullen, Mark Pierce, Laura B Martin, Kelly Rausch, Amagana Dolo, Dapa A Diallo, Louis H Miller, Ogobara K Doumbo
Vaccine 2010;27(52):7292-8